Foamix Pharmaceuticals - 48 Year Dividend History | FOMX
Historical dividend payout and yield for Foamix Pharmaceuticals (FOMX) since 1971. The current TTM dividend payout for Foamix Pharmaceuticals (FOMX) as of November 13, 2019 is $0.00. The current dividend yield for Foamix Pharmaceuticals as of November 13, 2019 is 0.00%.
||Medical - Drug Manufacturing
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company's lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.